Encompass Health reports Q3 2025 results; specific figures not available in filing excerpt

Encompass Health Corp

2025-Q3 EPS reported $4.11 vs consensus $1.21 ▲ beat (+240.6%)

Press release and supplemental slides for Q3 2025 furnished; no revenue or EPS extracted from provided text.
Company will discuss results on October 30, 2025 earnings call.
Non-GAAP measures (adjusted EPS, Adjusted EBITDA, adjusted free cash flow) are highlighted in the filing.
Same-store comparisons used; impact of market consolidation and capacity expansions included.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.